Assertio Therapeutics's market cap is currently ―. The company's EPS TTM is $-3.974; its P/E ratio is -0.23; Assertio Therapeutics is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.03. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 32.98M	$ 35.63M	$ 40.99M	$ 42.47M	$ 50.35M
Gross Profit	$ 23.26M	$ 28.57M	$ 36.22M	$ 42.47M	$ 50.35M
EBIT	$ -21.23M	$ -228.13M	$ 13.08M	$ -4.47M	$ 9.89M
EBITDA	$ -16.22M	$ -217.67M	$ 19.66M	$ 2.16M	$ 9.52M
Net Income Common Stockholders	$ -57.38M	$ -279.54M	$ 8.47M	$ -3.48M	$ 88.55M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 73.44M	$ 76.89M	$ 70.17M	$ 68.60M	$ 64.94M
Total Assets	$ 286.42M	$ 380.03M	$ 405.18M	$ 414.27M	$ 413.91M
Total Debt	$ 38.51M	$ 38.87M	$ 38.25M	$ 38.62M	$ 66.87M
Net Debt	$ -34.93M	$ -38.02M	$ -31.92M	$ -29.98M	$ 1.93M
Total Liabilities	$ 148.42M	$ 187.16M	$ 150.91M	$ 163.61M	$ 188.19M
Stockholders Equity	$ 138.00M	$ 192.87M	$ 254.27M	$ 250.66M	$ 225.72M
Cash Flow	-
Free Cash Flow	$ 5.89M	$ 2.58M	$ 17.90M	$ 22.61M	$ 26.42M
Operating Cash Flow	$ 5.71M	$ 2.58M	$ 18.60M	$ 22.72M	$ 26.70M
Investing Cash Flow	$ -239.00K	$ 4.14M	$ -703.00K	$ -105.00K	$ -25.78M
Financing Cash Flow	$ -8.91M	$ -10.00K	$ -16.33M	$ -18.95M	$ -798.00K

Currency in USD

Assertio Therapeutics Earnings and Revenue History

Income Statement >

Assertio Therapeutics Debt to Assets

Balance Sheet >

Assertio Therapeutics Cash Flow

Cash Flow >

Assertio Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing